I am dedicated to developing innovative probes designed for studying post-translational modification (PTM) proteins. These specialized probes will be employed in conjunction with mass spectrometry-based proteomics techniques, with the aim of revealing and clarifying abnormal PTMs associated with disease progression. My overarching goal is to provide novel and invaluable insights into the underlying mechanisms of pathogenesis, ultimately facilitating targeted therapeutic interventions.

Additionally, I am engaged in elucidating the toxic mechanisms of xenobiotics, harnessing state-of-the-art bioanalytical instruments within the laboratory setting. The objective is to trace chemical reactive metabolites and decipher their profound impact on various physiological processes. This endeavor holds the potential to offer valuable insights into the intricate relationship between toxic compounds and living organisms, potentially paving the way to mitigate the toxicity of these toxins.